Diagnostic Biochemistry of Calcium and Bone Disorders Flashcards
1
Q
Calcium Homeostasis
- Leak: TRPV5 and TRPV6 channels (also known as … - intestine and … - kidney, respectively)
- Pump: … calcium ATPase, PMCA1b, … calcium per ATP to ADP
- OR: Basolateral …NA:…CA exhanger, NCX1 extruding calcium (secondarily active mechanism using Na gradient)
- Regulation: 1,25(OH)2D3 and PTH - what do these stand for?
A
- Leak: TRPV5 and TRPV6 channels (also known as ECaC2 - intestine and ECaC1 - kidney, respectively)
- Pump: Basolateral calcium ATPase, PMCA1b, one calcium per ATP to ADP
- OR: Basolateral 3NA:1CA exhanger NCX1 extruding calcium (secondarily active mechanism using Na gradient)
- Regulation: 1,25(OH)2D3 and PTH - what do these stand for - activated vitamin D and parathyroid hormone
2
Q
- Animal models have demonstrated that ECaC expression is regulated by …
- Gene transcription upregulated by … …. .; phosphorylation of channels and the insertion of ECaC rich vesicles is also available
- 1 alpha hydroxylation of Vit D activated in the kidney by … …
A
- Animal models have demonstrated that ECaC expression is regulated by 1,25 Vit D (activated Vitamin D)
- Gene transcription upregulated by active vitamin D; phosphorylation of channels and the insertion of ECaC rich vesicles is also available
- 1 alpha hydroxylation of Vit D activated in the kidney by parathyroid hormone
3
Q
Calcium Homeostasis - Sites of exchange/control
- … - Filter v Reabsorption
- … - Absorption v Secretion
- … - Formation v Resorption
A
- Kidney - Filter v Reabsorption
- GI tract - Absorption v Secretion
- Bone - Formation v Resorption
4
Q
Threats to Calcium Homeostasis
- Disorders of …, … or …
- Disorders of … gland
- Abnormal …. metabolism : intake/synthesis/metabolism
A
- Disorders of gut, kidney or skeleton
- Disorders of parathyroid gland
- Abnormal vit D metabolism : intake/synthesis/metabolism
5
Q
Parathyroid Hormone
- Secreted as 84aa ‘…’ hormone
- Active moiety
- Key plasma measurement (not fragments)
- Half life approx … mins
- Low … inhibits release (mimicking ‘hypoparathyroidism’)
- Stimuli to release:
- Fall in plasma ionised … (Acute)
- Rise in plasma … (Chronic)
A
- Secreted as 84aa ‘intact’ hormone
- Active moiety
- Key plasma measurement (not fragments)
- Half life approx 4 mins
- Low magnesium inhibits release (mimicking ‘hypoparathyroidism’)
- Stimuli to release:
- Fall in plasma ionised calcium (Acute)
- Rise in plasma phosphate (Chronic)
6
Q
Parathyroid Hormone vs PTH related peptide
- Laboratory assay picks up … only, it DOES NOT detect …
- … secreted by a wide variety of tumours, contributes to the humeral hypercalcaemia of malignancy
- … acts as a calciotropic hormone in fetal life and in lactation
- … stimulates the transport of calcium across the placenta
- … probably contributes to the dramatic but largely reversible bone loss during lactation
A
- Laboratory assay picks up PTH only, it DOES NOT detect PTHrP
- PTHrP secreted by a wide variety of tumours, contributes to the humeral hypercalcaemia of malignancy
-
PTHrP acts as a calciotropic hormone in fetal life and in lactation
- PTHrP stimulates the transport of calcium across the placenta
- PTHrP probably contributes to the dramatic but largely reversible bone loss during lactation
7
Q
Vitamin D
- D… and D… ( light) sources
- Activation of … via hepatic (25-hydroxylase*) & renal … (1a -hydroxylase) steps
- *constitutive & this is the measurand
- When exposed to … 7-dehydrocholesterol undergoes photochemical … forming vitamin D
A
- Dietary and Dermal ( light) sources
- Activation of cholecalciferol via hepatic (25-hydroxylase*) & renal hydroxylation (1a -hydroxylase) steps
- *constitutive & this is the measurand
- When exposed to UV light 7-dehydrocholesterol undergoes photochemical cleavage forming vitamin D
8
Q
Vitamin D nomenclature
- Vitamin D2 (Or …) refers to Vitamin D from … sources and Vitamin D3 (or …) from … sources
- Product of first hydroxylation (liver)
- D2 - …-hydroxyvitamin D2 or ercalciferol
- D3 - …-hydroxyvitamin D3 or calcidiol
- Product of second hydroxylation (kidney)
- 1,25-Dihydroxyvitamin D2 or …
- 1,25-Dihydroxyvitamin D3 or …
A
- Vitamin D2 (Or ergocalciferol) refers to Vitamin D from plant sources and Vitamin D3 (or cholecalciferol) from animal sources
- Product of first hydroxylation (liver)
- D2 - 25-hydroxyvitamin D2 or ercalciferol
- D3 - 25-hydroxyvitamin D3 or calcidiol
- Product of second hydroxylation (kidney)
- 1,25-Dihydroxyvitamin D2 or ercalcitriol
- 1,25-Dihydroxyvitamin D3 or calcitriol
9
Q
Calcitonin
- Main effect: to reduce bone … (direct and reversible effect on …)
- Role uncertain, thought to protect the skeleton during stressors such as in …
- Main use: tumour marker for medullary … of the …
A
- Main effect: to reduce bone resorption (direct and reversible effect on osteoclasts)
- Role uncertain, thought to protect the skeleton during stresses (growth and pregnancy)
- Main use: tumour marker for medullary carcinoma of the thyroid
10
Q
FGF-23
- Secreted by osteo…, osteo… and osteo… in response to raised serum …
- Reduces … reabsorption in the renal proximal tubule and inhibits 1-α …
- May be important in renal … disease
A
- Secreted by osteocytes, osteoblasts and osteoclasts in response to raised serum phosphate
- Reduces phosphate reabsorption in the renal proximal tubule and inhibits 1-α hydroxylase
- May be important in renal bone disease
11
Q
Total Plasma Calcium - Interpretation?
- Total plasma calcium is what is measured in the lab – a … method
- However …% ionised: physiologically active, regulated tightly, measured by blood gas machine
- …% albumin bound
- … % complexed
- Change in … changes the total calcium (lab method).
- We … therefore and present a range ‘if the albumin were 40 g/L’
A
- Total plasma calcium is what is measured in the lab – a dye method
- However 50% ionised: physiologically active, regulated tightly, measured by blood gas machine
- 40% albumin bound
- 10 % complexed
- Change in albumin changes the total calcium (lab method).
- We adjust therefore and present a range ‘if the albumin were 40 g/L’
12
Q
‘Adjustment’ of Plasma Calcium Results
- Method and population specific adjustment to make data fit the range: …-… mmol/L
- Adjusted calcium = calcium +0.02 x (40-albumin)
- Consider 3 patients:
- Calcium 2.40 Albumin 40 Adjusted Calcium = ?
- Calcium 2.16 Albumin 30 Adjusted Calcium = ?
- Calcium 2.64 Albumin 50 Adjusted Calcium = ?
A
- Method and population specific adjustment to make data fit the range: 2.20-2.60 mmol/L
- Adjusted calcium = calcium +0.02 x (40-albumin)
- Consider 3 patients:
- Calcium 2.40 Albumin 40 Adjusted Calcium = ?
- Calcium 2.16 Albumin 30 Adjusted Calcium = ? 2.36
- Calcium 2.64 Albumin 50 Adjusted Calcium = ? 2.44
13
Q
Hypercalcaemia + Suppressed PTH
- ?parathyroid cause
- … (E.g. lung, breast or blood)
- … excess (Activated)
- Sar…
A
-
Non-parathyroid cause
- Malignancy (E.g. lung, breast or blood)
- Vit D excess (Activated)
- Sarcoidosis
14
Q
Hypercalcaemia + Raised (or detectable) PTH
- PTH mediated cause?
- … hyperparathyroidism
- … hyperparathyroidism
- … hyperparathyroidism
- (+ calcium … defects e.g. FHH)
A
-
PTH mediated cause
- Primary hyperparathyroidism
- Secondary hyperparathyroidism
- Tertiary hyperparathyroidism
- (+ calcium receptor defects e.g. FHH)
15
Q
Hypocalcaemia + Increased PTH:
- ?parathyroid cause
- Vit D …, mal…
- … failure
- (PTH … defect e.g. pseudohypoparathyroidism)
- (Vit D … defect)
A
- Non-parathyroid cause
- Vit D deficiency, malabsorption
- Renal failure
- (PTH receptor defect e.g. pseudohypoparathyroidism)
- (Vit D receptor defect)